ContractJoint Venture Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
SECOND AMENDED AND RESTATED JOINT VENTURE AGREEMENTJoint Venture Agreement • November 7th, 2018 • Novavax Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 7th, 2018 Company IndustryCadila Pharmaceuticals Limited, a company incorporated under the laws of India having its office at ‘Cadila Corporate Campus’, Sarkhej-Dholka Road, Bhat, Ahmedabad - 382210, Gujarat, India herein represented by Dr. Rajiv I. Modi in his capacity as Chairman & Managing Director (hereinafter referred to as “Cadila”) which expression shall unless repugnant to the context or meaning thereof mean and include its scuccessors and permitted assigns and;